← FDA Drug Approvals (Drugs@FDA)

GEMCITABINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2018-07-20

Drug application

FDA Application #
ANDA209077
Application type
Abbreviated New Drug Application (Generic)
Brand name
GEMCITABINE HYDROCHLORIDE
Generic name
GEMCITABINE
Active ingredients
GEMCITABINE HYDROCHLORIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
SAGENT PHARMS INC
Manufacturer
Sagent Pharmaceuticals
First approval
2018-07-20

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown